In antibody–drug conjugate (ADC) development, knowing where your drug goes and whether it’s doing what you designed it to do can make the difference between success and costly setbacks. Radiochemistry offers a powerful way to generate that insight, using radioactive isotopes to “tag” antibodies, payloads, or both so their journey through the body can be tracked with precision.
.jpg)